As Trump’s trade war led stocks to post their worst first quarter since 2022, diversification proved its worth.
Roche Holding said it will initiate a late-stage trial for its Alzheimer's drug candidate trontinemab later this year after its mid-stage study showed positive results.
Less than half (46%) of U.S. adults have a will, according to Gallup. Adults aged 65 and older are the most likely cohort to have a will, with 76% saying they have one, the polling firm found. But ...
President Donald Trump's tariff plans have been delivering plenty of shock and awe across global markets. Closer to home, futures are pointing to a 1,200-point-plus plunge for the Dow industrials DJIA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results